Company / SG&A per Share
Bausch Health Companies Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$9.35
FY2025
5-year range
$6.59 / $9.35
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#16 of 210
Health Care
What the data says
Among 210 Health Care companies, Bausch Health Companies Inc. is in the bottom 8% for sg&a per share. SG&A per Share has increased for 3 consecutive years, from $6.59 in FY2022 to $9.35 in FY2025.
Based on SEC 10-K filings.
9.35 in FY2025 with a 5-year CAGR of +5.9%. Top quartile in the Health Care sector.
Increased from $7.25 to $9.35 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 210This company $9.35 Sector average $29.50
▼
-68.3% below sector average
Key checks
Key Insights
- Bausch Health Companies Inc.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 3.6% year-over-year.
- Ranks #16 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.35 | +3.6% |
| FY2024 | $9.02 | +24.5% |
| FY2023 | $7.25 | +10.1% |
| FY2022 | $6.59 | -10.8% |
| FY2021 | $7.38 | +5.3% |
| FY2020 | $7.01 | -5.0% |
| FY2019 | $7.38 | -8.4% |
| FY2018 | $8.06 | +8.6% |
| FY2017 | $7.42 | -9.4% |
| FY2016 | $8.19 | +1.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026